FESTEL CAPITAL

Maintaining health and well-being into old age is one of the most important aspects of modern life. Innovative medicines and medical technology are making a valuable contribution to public health.

FESTEL CAPITAL supports the commercialisation of innovative technologies as well as works together with both founders of academic spin offs and international companies to create and develop new technology based businesses.

FESTEL CAPITAL also invests in selected businesses mainly in the seed phase of start-up companies.

Descriptions of technologies currently in our portfolio are given below.

Industrial partners and financial investors are sought for various possible commercialisation options.

Commercialisation

Drug delivery system for various active agents and time controlled release. 

Innovative antibacterial-active agent for dental polymer fillings.

Innovative precursor coating that increases wear resistance and reduces the liberation of metal ions from implants.

Microfluidic Device for Patterned Surface Modification: A highly parallel microfluidic device maintaining protein integrity.

Modified synthetic tissue for the laparoscopic repair of hernias.

Multi-sensor array instrument for online measurements in cell and tissue cultures.

Wound Healing Composition based on a Synthetic Wound Healing Peptide   

Start ups

Autodisplay Biotech GmbH is active in the area of autodisplay technology, which enables a cost efficient production of biocatalysts, pharmaceutical proteins and medicines.

www.autodisplay-biotech.com

BayGenetics GmbH is active in the field of the micro organism Bacillus subtilis (B. subtilis). Interesting application possibilities in the areas of protein synthesis and enzyme catalysts have already been developed.

www.baygenetics.com

           Disclaimer         Privacy Policy          Terms of Use          Site Map          Imprint        

 © FESTEL CAPITAL